Valuation: Boston Scientific Corporation

Market Cap 69.81B 360B 59.92B 56.24B 51.36B 96.94B 6,658B 97.41B 666B 258B 3,359B 262B 256B 11,126B P/E 2026 *
18x
P/E 2027 * 19x
Enterprise Value 78.53B 405B 67.4B 63.26B 57.78B 109B 7,490B 110B 749B 290B 3,778B 295B 288B 12,515B EV / Sales 2026 *
3.68x
EV / Sales 2027 * 3.37x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day-75.53%
1 week-8.08%
Current month+4.80%
1 month+5.69%
3 months-14.28%
6 months-36.70%
Current year-52.91%
1 week 60.93
Extreme 60.93
65.65
1 month 54.78
Extreme 54.78
68.39
Current year 50.29
Extreme 50.2875
135.68
1 year 50.29
Extreme 50.2875
147.75
3 years 50.29
Extreme 50.2875
153.78
5 years 45.16
Extreme 45.165
153.78
10 years 33.62
Extreme 33.615
153.78
Manager TitleAgeSince
Chief Executive Officer 61 2011-10-31
Director of Finance/CFO 52 2025-06-29
Chief Tech/Sci/R&D Officer - 2009-08-31
Director TitleAgeSince
Chairman 61 2016-05-02
Director/Board Member 74 2014-02-28
Director/Board Member 74 2016-04-14
Change 5-day change 1-year change 3-year change Capi.($)
-75.53%-8.08% - - 72.26B
+0.89%+3.29%+29.73%+17.01% 232B
-0.28%+1.83%+4.42%-15.72% 152B
-0.38%-6.86%-21.90%+24.49% 131B
-3.39%-7.38%-54.72%-5.10% 72.26B
-0.10%-1.63%+11.70%+19.18% 52.38B
-1.11%-1.80%-16.89%-13.58% 51.57B
+0.20%-0.21%+31.09%+29.58% 43.71B
-0.07%-0.40%+39.86%+51.51% 40.72B
-0.38%+2.19%-17.35%+46.41% 34.13B
Average -8.01%+0.04%+0.66%+17.09% 90.02B
Weighted average by Cap. -6.41%-0.08%+3.55%+11.96%

Financials

2026 *2027 *
Net sales 21.37B 110B 18.34B 17.21B 15.72B 29.67B 2,038B 29.81B 204B 78.94B 1,028B 80.22B 78.48B 3,405B 22.33B 115B 19.17B 17.99B 16.43B 31.01B 2,130B 31.16B 213B 82.5B 1,074B 83.84B 82.02B 3,559B
Net income 3.84B 19.81B 3.3B 3.09B 2.82B 5.33B 366B 5.36B 36.6B 14.18B 185B 14.41B 14.1B 612B 3.69B 19.02B 3.16B 2.97B 2.71B 5.12B 352B 5.14B 35.14B 13.62B 177B 13.84B 13.54B 587B
Net Debt 8.72B 44.98B 7.48B 7.02B 6.41B 12.1B 831B 12.16B 83.11B 32.21B 419B 32.73B 32.02B 1,389B 5.45B 28.13B 4.68B 4.39B 4.01B 7.57B 520B 7.61B 51.98B 20.14B 262B 20.47B 20.03B 869B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
26-08-26 R$62.21 -3.08% 813
26-08-25 R$64.19 +2.18% 573
26-08-24 R$62.82 -3.13% 3,103
26-08-21 R$64.85 +0.19% 18
26-08-20 R$64.73 -4.36% 37
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
48.17USD
Average target price
62.69USD
Spread / Average Target
+30.14%

Quarterly revenue - Rate of surprise